Latest Breaking News On - Development at centessa pharmaceuticals ltd - Page 1 : comparemela.com

/PRNewswire/ Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Antoine Yver as Chairman of SAB. Dr. Antoine.

France generalUnited statesJohn zhuRhone poulenc rorerDaiichi sankyoAntoine yverDuality biotherapeutics incDevelopment at centessa pharmaceuticals ltdAventis groupUniversity of parisAntibody drug conjugatesCentessa pharmaceuticalsExecutive vice presidentGlobal headCancer enterpriseSenior vice president